BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 34073635)

  • 1. New Pathological and Clinical Insights in Endometrial Cancer in View of the Updated ESGO/ESTRO/ESP Guidelines.
    Santoro A; Angelico G; Travaglino A; Inzani F; Arciuolo D; Valente M; D'Alessandris N; Scaglione G; Fiorentino V; Raffone A; Zannoni GF
    Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34073635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of endometrial carcinoma histotype on the prognostic value of the TCGA molecular subgroups.
    Travaglino A; Raffone A; Stradella C; Esposito R; Moretta P; Gallo C; Orlandi G; Insabato L; Zullo F
    Arch Gynecol Obstet; 2020 Jun; 301(6):1355-1363. PubMed ID: 32296930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Genetics of Endometrial Carcinoma.
    Bell DW; Ellenson LH
    Annu Rev Pathol; 2019 Jan; 14():339-367. PubMed ID: 30332563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-grade endometrial carcinomas: Morphologic spectrum and molecular classification.
    Zhang C; Zheng W
    Semin Diagn Pathol; 2022 May; 39(3):176-186. PubMed ID: 34852949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TCGA Molecular Prognostic Groups of Endometrial Carcinoma: Current Knowledge and Future Perspectives.
    Arciuolo D; Travaglino A; Raffone A; Raimondo D; Santoro A; Russo D; Varricchio S; Casadio P; Inzani F; Seracchioli R; Mollo A; Mascolo M; Zannoni GF
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36232987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classification of Endometrial Carcinoma: New Perspectives Beyond Morphology.
    Akhtar M; Al Hyassat S; Elaiwy O; Rashid S; Al-Nabet ADMH
    Adv Anat Pathol; 2019 Nov; 26(6):421-427. PubMed ID: 31567131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of
    Beinse G; Rance B; Just PA; Izac B; Letourneur F; Saidu NEB; Chouzenoux S; Nicco C; Goldwasser F; Batteux F; Durdux C; Chapron C; Pasmant E; Leroy K; Alexandre J; Borghese B
    Int J Gynecol Cancer; 2020 May; 30(5):640-647. PubMed ID: 32169874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interobserver Agreement in Endometrial Carcinoma Histotype Diagnosis Varies Depending on The Cancer Genome Atlas (TCGA)-based Molecular Subgroup.
    Hoang LN; Kinloch MA; Leo JM; Grondin K; Lee CH; Ewanowich C; Köbel M; Cheng A; Talhouk A; McConechy M; Huntsman DG; McAlpine JN; Soslow RA; Gilks CB
    Am J Surg Pathol; 2017 Feb; 41(2):245-252. PubMed ID: 28079598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated clinicopathologic and molecular analysis of endometrial carcinoma: Prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification and proposal of histopathologic algorithm for its implementation in clinical practice.
    de Biase D; Maloberti T; Corradini AG; Rosini F; Grillini M; Ruscelli M; Coluccelli S; Altimari A; Gruppioni E; Sanza V; Turchetti D; Galuppi A; Ferioli M; Giunchi S; Dondi G; Tesei M; Ravegnini G; Abbati F; Rubino D; Zamagni C; De Iaco P; Santini D; Ceccarelli C; Perrone AM; Tallini G; De Leo A
    Front Med (Lausanne); 2023; 10():1146499. PubMed ID: 37064027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genetic landscape of endometrial clear cell carcinomas.
    DeLair DF; Burke KA; Selenica P; Lim RS; Scott SN; Middha S; Mohanty AS; Cheng DT; Berger MF; Soslow RA; Weigelt B
    J Pathol; 2017 Oct; 243(2):230-241. PubMed ID: 28718916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reclassifying endometrial carcinomas with a combined morphological and molecular approach.
    Carlson J; McCluggage WG
    Curr Opin Oncol; 2019 Sep; 31(5):411-419. PubMed ID: 31261170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TCGA Classification of Endometrial Cancer: the Place of Carcinosarcoma.
    Travaglino A; Raffone A; Gencarelli A; Mollo A; Guida M; Insabato L; Santoro A; Zannoni GF; Zullo F
    Pathol Oncol Res; 2020 Oct; 26(4):2067-2073. PubMed ID: 32472441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of mutational signatures in primary and metastatic endometrial cancer reveals distinct patterns of DNA repair defects and shifts during tumor progression.
    Ashley CW; Da Cruz Paula A; Kumar R; Mandelker D; Pei X; Riaz N; Reis-Filho JS; Weigelt B
    Gynecol Oncol; 2019 Jan; 152(1):11-19. PubMed ID: 30415991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant Treatment Recommendations in Early-Stage Endometrial Cancer: What Changes With the Introduction of The Integrated Molecular-Based Risk Assessment.
    Nero C; Ciccarone F; Pietragalla A; Duranti S; Daniele G; Scambia G; Lorusso D
    Front Oncol; 2021; 11():612450. PubMed ID: 34540651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma.
    Concin N; Creutzberg CL; Vergote I; Cibula D; Mirza MR; Marnitz S; Ledermann JA; Bosse T; Chargari C; Fagotti A; Fotopoulou C; González-Martín A; Lax SF; Lorusso D; Marth C; Morice P; Nout RA; O'Donnell DE; Querleu D; Raspollini MR; Sehouli J; Sturdza AE; Taylor A; Westermann AM; Wimberger P; Colombo N; Planchamp F; Matias-Guiu X
    Virchows Arch; 2021 Feb; 478(2):153-190. PubMed ID: 33604759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular insights into the classification of high-grade endometrial carcinoma.
    Hussein YR; Soslow RA
    Pathology; 2018 Feb; 50(2):151-161. PubMed ID: 29246451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Genomic Heterogeneity of FIGO Grade 3 Endometrioid Carcinoma Impacts Diagnostic Accuracy and Reproducibility.
    Hussein YR; Broaddus R; Weigelt B; Levine DA; Soslow RA
    Int J Gynecol Pathol; 2016 Jan; 35(1):16-24. PubMed ID: 26166718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma.
    Concin N; Matias-Guiu X; Vergote I; Cibula D; Mirza MR; Marnitz S; Ledermann J; Bosse T; Chargari C; Fagotti A; Fotopoulou C; Martin AG; Lax S; Lorusso D; Marth C; Morice P; Nout RA; O'Donnell D; Querleu D; Raspollini MR; Sehouli J; Sturdza A; Taylor A; Westermann A; Wimberger P; Colombo N; Planchamp F; Creutzberg CL
    Radiother Oncol; 2021 Jan; 154():327-353. PubMed ID: 33712263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Undifferentiated-dedifferentiated endometrial carcinoma; the reappearance of an old friend with insights into the new data.
    Mourtzoukou D; Thomakos N; Lazaris AC; Vlachodimitropoulos D; Goutas N; Sotiropoulou M; Rodolakis A; Nonni A
    APMIS; 2023 Jun; 131(6):229-236. PubMed ID: 36965090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TCGA Molecular Subgroups in Endometrial Undifferentiated/Dedifferentiated Carcinoma.
    Travaglino A; Raffone A; Mascolo M; Guida M; Insabato L; Zannoni GF; Zullo F
    Pathol Oncol Res; 2020 Jul; 26(3):1411-1416. PubMed ID: 31811476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.